Literature DB >> 10944652

Assessment and diagnosis of attention-deficit/hyperactivity disorder.

L Hechtman1.   

Abstract

ADHD is the most common psychiatric disorder of childhood (3% to 5% of children) with continued morbidity into adolescence (85%) and adulthood (50% to 70%). It is a condition associated with widespread significant impairment in academic, occupational, social, and emotional functioning. It is also a condition with a broad extensive differential diagnosis as well as a high rate of comorbidity. There is no diagnostically definitive test for ADHD. Therefore, assessments for ADHD need to be comprehensive and should involve multiple domains, informants, methods, and settings. The comprehensive assessment needs to determine whether the subject has ADHD or another disorder. Thus, evaluation of various organic conditions, functional disorders, developmental status, situational, environmental, and family problems should all be explored. The clinical interview of the child and family is one of the cornerstones of the assessment process. A comprehensive medical history and examination, psychoeducational tests, and school-related evaluation, as well as a view of the child's social and emotional functioning, are also crucial. A wide array of rating scales, tests, and measures have been developed (see Table 1) to aid in the systematic standardized assessment of the various deficits associated with ADHD. None of these tests is definitive, however. Recent development of tests of executive functioning, neuroimaging, and genetics may provide more exact diagnostic guidelines in the future. Current DSM-IV criteria are phenomenologic rather than etiologic and are much more relevant and appropriate for children with ADHD compared with adolescents and adults. A comprehensive assessment involving various domains of functioning (academic, social, emotional, physical, and familial) provide not only more accurate diagnosis but also directions as to what difficulties exist and what multifaceted treatment plan is needed to produce current improvement and long-term positive outcome.

Entities:  

Mesh:

Year:  2000        PMID: 10944652

Source DB:  PubMed          Journal:  Child Adolesc Psychiatr Clin N Am        ISSN: 1056-4993


  17 in total

1.  Factors related to health-related quality of life (HRQoL) among children with ADHD in Europe at entry into treatment.

Authors:  Anne W Riley; Georg Spiel; David Coghill; Manfred Döpfner; Bruno Falissard; Maria J Lorenzo; Ulrich Preuss; Stephen J Ralston
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-12       Impact factor: 4.785

Review 2.  Behavioural problems and attention-deficit hyperactivity disorder in children with enuresis: a literature review.

Authors:  Dieter Baeyens; Herbert Roeyers; Johan Vande Walle; Piet Hoebeke
Journal:  Eur J Pediatr       Date:  2005-07-12       Impact factor: 3.183

3.  Acute and chronic psychostimulant treatment modulates the diurnal rhythm activity pattern of WKY female adolescent rats.

Authors:  Cathleen G Jones; Pamela B Yang; Victor T Wilcox; Keith D Burau; Nachum Dafny
Journal:  J Neural Transm (Vienna)       Date:  2014-01-31       Impact factor: 3.575

Review 4.  Attention-deficit/hyperactivity disorder: a neuropsychological perspective towards DSM-V.

Authors:  Gerry A Stefanatos; Ida Sue Baron
Journal:  Neuropsychol Rev       Date:  2007-03       Impact factor: 7.444

5.  Psychometric properties of the Chinese version of the adult ADHD Self-report Scale.

Authors:  Chin-Bin Yeh; Susan Shur-Fen Gau; Ronald C Kessler; Yu-Yu Wu
Journal:  Int J Methods Psychiatr Res       Date:  2008       Impact factor: 4.035

6.  The development of hyperactive-impulsive behaviors during the preschool years: the predictive validity of parental assessments.

Authors:  Nancy Leblanc; Michel Boivin; Ginette Dionne; Mara Brendgen; Frank Vitaro; Richard E Tremblay; Daniel Pérusse
Journal:  J Abnorm Child Psychol       Date:  2008-10

7.  Psychometric properties of two ADHD questionnaires: comparing the Conners' scale and the FBB-HKS in the general population of German children and adolescents--results of the BELLA study.

Authors:  Michael Erhart; Manfred Döpfner; Ulrike Ravens-Sieberer
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-12       Impact factor: 4.785

Review 8.  Use of atomoxetine in patients with attention-deficit hyperactivity disorder and co-morbid conditions.

Authors:  Grazia Dell'Agnello; Alessandro Zuddas; Gabriele Masi; Paolo Curatolo; Dante Besana; Andrea Rossi
Journal:  CNS Drugs       Date:  2009-09       Impact factor: 5.749

9.  Disparities in identification of comorbid diagnoses in children with ADHD.

Authors:  Tanjala T Gipson; Eboni I Lance; Rebecca A Albury; Maura B Gentner; Mary L Leppert
Journal:  Clin Pediatr (Phila)       Date:  2014-10-10       Impact factor: 1.168

Review 10.  Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants.

Authors:  Jan Buitelaar; Rossella Medori
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-10-13       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.